Sarcoplasmic reticulum Ca2+ATPaSe and phospholamban mRNA and protein levels in end-stage heart failure due to ischemic or dilated cardiomyopathy

Journal of Molecular Medicine

Volumn 74, Issue 6, 1996, Pages 321-332

  Flesch, M ^a   Schwinger, R H G ^a   Schnabel, P ^a   Schiffer, F ^a   Van Gelder, I ^a   Bavendiek, U ^a   Sudkamp M ^a   Kuhn Regnier, F ^a   Bohm M ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

cAMP; Heart failure; Human left ventricle; Phospholamban; Sarcoplasmic reticulum Ca2+ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM ION; CYCLIC AMP; MESSENGER RNA; PHOSPHOLAMBAN; ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CALCIUM BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADULT; ARTICLE; CALCIUM METABOLISM; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE; HUMAN; HUMAN TISSUE; MALE; PATHOGENESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; SARCOPLASMIC RETICULUM; BIOSYNTHESIS; CHEMISTRY; COMPARATIVE STUDY; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; DIASTOLE; ENZYMOLOGY; GENETICS; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE; METABOLISM; MIDDLE AGED;

CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CARDIOMYOPATHY, DILATED; DIASTOLE; FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RNA, MESSENGER; SARCOPLASMIC RETICULUM;

EID: 0029661951     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00207509     Document Type: Article

References (61)

1. Katz AM (1990) Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med 322:100-110
2. Gwathmey JK, Copelas L, Mackkinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP (1987) Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61:70-76
3. Schwinger RHG, Böhm M, Erdmann E (1992) Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. Am Heart J 123:116-128
4. Morgan JP, Raymond EE, Paul A, Grossman W, Gwathmey JK (1990) Abnormal intracellular calcium handling as a major cause of systolic and diastotic dysfunction in ventricular myocardium from patients with heart failure. Circulation 81 [Suppl III]:21-32
5. Gwathmey JK, Sanford EW, Briggs GM, Copelas L, Feldman MD, Preston JP, Callahan M, Schoen FJ, Grossman W, Morgan JP (1991) Diastolic dysfunction in hypertrophic cardiomyopathy. J Clin Invest 87:1023-1031
6. Morgan JP (1991) Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325:625-632
7. Beuckelmann DJ, Nabauer M, Erdmann E (1992) Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85:1046-1055
8. Lamers JHJ, Satinis JT (1979) Defective calcium pump in the sarcoplasmic reticulum of the hypertrophied rabbit heart. Life Sci 24:2313-2320
9. 2+ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 66:554-564
10. 2+ATPase and function of sarcoplasmic reticulum during cardiac hypertrophy. Am J Physiol 256:H1006-H1011
11. Kuo TH. Tsaang W, Wang KK, Carlock L (1992) Simultaneous reduction of the sarcolemmal and SR calcium ATPase activities and gene expression in cardiomyopathic hamster. Biochim Biophys Acta 1138:343-349
12. Limas CL, Olivari M-T, Goldenberg IF, Levine TB, Benditt DG, Simon A (1987) Calcium uptake by cardiac sarcoplasmic reticulum in human dilated cardiomyopathy. Cardiovasc Res 21:601-605
13. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 75:434-442
14. Arai M, Matsui H, Periasamy M (1994) Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circulation 74:555-564
15. 2+ uptake by cardiac sarcoplasmic reticulum from patients with idiopathic dilated cardiomyopathy. Circ Res 65:1141-1144
16. Bristow MR, Ginsburg R, Minobe W, Cubiciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB (1982) Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med 307:205-211
17. Feldman AM, Cates AE, Veazey WB, Hershberger RE, Bristow MR, Baughman KL, Baumgartner WA, Van Dop C (1988) Increase in the 40,000-mol wt pertussis toxin substrate (G-protein) in the failing human heart. J Clin Invest 82: 189-197
18. Böhm M, Gierschik P, Jakobs KH, Pieske B, Schnabel P, Lingerer M, Erdmann E (1990) Increase of Giα in human hearts with dilated but not ischemic cardiomyopathy. Circulation 82: 1249-1265
19. Böhm M, Eschenhagen T, Gierschik P, Larisch K, Lensche H, Mende U, Schmitz W, Schnabel P, Scholz H, Steinfath M, Erdmann Ei (1994) Radioimmunochemical quantfication of Giα in right and left ventricles from patients with ischaemic and dilated cardiomyopathy and predominant left ventricular failure. J Mol Cell Cardiol 26:113-149
20. Danielsen W, von der Leyen H, Meyer W, Neumann J, Schmitz W, Scholz H, Starbatty J, Stein B, Doring V, Kalmar P (1989) Basal and isoprenaline-stimulated cAMP content in failing versus nonfailing human cardiac preparations. J Cardiovasc Pharmacol 14:171-173
21. Jones LR (1985) Sarcolemmal enzymes mediating β-adrenergic effects on the heart. In Bronner FA, Shamoo AE (eds) Current topics in membranes and transport; regulation of caclium transport across muscle membranes. Academic, New York, pp 11-41
22. 2+-ATPase activity in guinea pig ventricles. J Biol Chem 258:464-471
23. Karczewski P, Bartel S, Krause EG (1990) Differential sensitivity to isoproterenol of phospholamban and troponin 1 phosphorylation in isolated rat hearts. Biochem J 266:115-122
24. Colyer J, Wang JH (1991) Dependence of cardiac sarcoplasmic reticulum calcium pump activity on the phosphorylation status of phospholamban. J Biol Chem 266:17486-17493
25. Mattiazzi A, Hove-Madsen L, Bers DM (1994) Protein kinase inhibitors reduce SR Ca transport in permeabilized cardiac myocytes. Am J Phys 267: H812-H820
26. 2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci USA 86:2966-2970
27. 2+-ATPase gene expression in the human ventricle during end-stage heart failure. J Clin Invest 85:305-309
28. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR (1991) Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation 83:1866-1872
29. 2+ ATPase in failing and nonfailing human hearts. Cardiovasc Res (1996); in press
30. 2+-ATPase gene. Circ Res 71:9-17
31. Arai M, Alpert NR, Mac Lennan DH, Barton P, Periasamy M (1993) Alterations in sarcoplasmic reticulum gene expression in human heart failure. Circ Res 72:463-469
32. 2+-dependent adenosine triphosphatase from rat cardiac sarcoplasmic reticulum. J Clin Invest 83:1102-1108
33. 2+-transporting ATPase, phospholamban, and calsequestrin levels in nonfailing and failing human myocardium. Circulation 90: 653-657
34. 2 in human end-stage heart failure. Circ Res 70:688-696
35. Bristow MR, Anderson FL, Port D, Skerls L, Hershberger RE, Larrabee P, O'Connell JB, Renlund DG, Volkman K, Murray J, Feldman AM (1991) Differences in β-adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 84:1024-1039
36. Brilliantes AM, Allen P, Takahashi T, Izumo S, Marks AR (1992) Differences in cardiac calcium release channel (ryanodine receptor) expression in myocardium from patients with end-stage heart failure caused by ischemic versus dilated cardiomyopathy. Circ Res 71:18-26
37. Chu A, Dixon MC, Saito A, Seiler S, Fleischer S (1988) Isolation of sarcoplasmic reticulum fractions referable to longitudinal tubules and junctional terminal cisternae from rabbit skeletal muscle. Meth Enzym 157:36-46
38. Fabiato A (1988) Computer programs for calculating total from specified free or free from specified total ionic concentrations in aequeous solutions containing multiple metals and ligands. Meth Enzym 157:378-417
39. Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidthiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
40. 2+-ATPase gene. J Biol Chem 263: 15024-15031
41. Fujii J, Zarain-Herzberg A, Willard HF, Tada M, MacLennan DH (1991) Structure of the rabbit phospholamban gene, cloning of the human cDNA. and assignment of the gene to human chromosome 6. J Biol Chem 266:11669-11675
42. i protein α-subunit: deduction of amino acid structure from a cloned cDNA. FEBS Lett 211:160-164
43. Böhm M, Reiger B, Schwinger RHG, Erdmann E (1994) cAMP concentrations, cAMP dependent protein kinase activity, and phospholamban in non-failing and failing myocardium. Cardiovasc Res 28:1713-1719
44. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 76:4350-4354
45. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurements with the folin phenol reagent. J Biol Chem 193:265-275
46. Dixon TF, Purdom M (1954) Serum 5′ nucleotidase. J Clin Pathol 7:341-351
47. Wallenstein S, Zucker CL, Fleiss JL (1980) Some statistical methods useful in circulation research. Circ Res 47:1-9
48. Tomplison CW, Godin DV, Rabkin SW (1985) Adriamycin cardiomyopathy: implications of cellular changes in a canine model with mild impairment of left ventricular function. Biochem Pharmacol 34:4033-4041
49. Burnett JC Jr, Keo PC, Hu DC, Heser DW, Heublein D, Granger JP, Opgenorth TJ, Reeder GS (1986) Atrial natriuretic peptide elevation in congestive heart failure in the human. Science 231:12145-1147
50. 2+ exchanger in end-stage human heart failure. Circ Res (1994); 75:443-453
51. 2+ pump blocking of phospholamban phosphorylation and dephosphorylation by a phospholamban monoclonal antibody. J Biol Chem (1986); 261:7918-7023
52. Li C, Wang JH, Colyer. Immunological detection of phospholamban phosphorylation states facilitates the description of the mechanism of phosphorylation and dephosphorylation. Biochemistry (1990); 29:4535-4540
53. Flesch M, Pütz F, Schwinger RHG, Paul M, Böhm M (1995) Altered sarcoplasmic reticulum gene expression in cardiac hypertrophy of renin transgenic rats corresponds to diastolic contractile dysfunction (abstract). Circulation [Suppl]:92:1-348
54. Linzbach AJ (1960) Heart failure from the viewpoint of quantitative anatomy. Am J Cardiol 5:370-382
55. Magid NM, Borer JS, Young MS, Wallerson DC, DeMonteiro C (1993) Suppression of protein degradation in progressive cardiac hypertrophy of chronic aortic regurgtation. Circulation 87:1249-1257
56. 2+ pump by cytosolic proteins endogenous to heart and slow skeletal muscle but not fast skeletal muscle. Biochim Biophys Acta 735:53-66
57. Chiesi M, Schwaller R (1987) Characterization of heart cytosolic proteins capable of modulating calcium uptake by the sarcoplasmic reticulum. II. Identification of actin isoforms with inhbitory activity. Eur J Biochem 162:371-377
58. Chiesi M, Guerini D (1987) Characterization of heart cytosolic proteins capable of modulating calcium uptake by the sarcoplasmic reticulum. 1. Isolation of a protein with protective activity and ist identification as muscle albumin. Eur J Biochem 162:365-370
59. Böhm M, Beuckelmann DJ, Brown L, Feiler G, Lorenz B, Näbauer M, Kemkes B, Erdmann E (1988) Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium. Eur Heart J 9:844-852
60. Bristow MR, Ginsburg R, Strosberg A, Montgomery W, Minobe W (1984) Pharmacology and inotropic potential of forskolin in the human heart. J Clin Invest 74:212-223
61. Mulieri LA, Bruce JL, Martin BJ, Haeberle JR, Alpert NR (1993) Myocardial force-frequency defect in mitral regurgitation heart failure is reversed by forskolin. Circulation 88: 2700-2704